Search

Magnus P Ronn

from Melrose, MA
Age ~58
Get Report
Also known as:
Magnus Sarah Ronn, Magnus Sara Ronn, Magnus M Ronn, Magnus S Ronn, Ronn Magnus, S Ronn
Phone and address:
3 Irving St, Melrose, MA 02176
(781) 620-1181
Connected to:
Lance D Ronn, 52Susan M Ronn, 58Jason A Ronna, 53Andrew Ronnau, 62Todd D Ronnau, 53Jeff G Ronne, 64Joseph F Ronne, 80Robert P Ronne, 74Robert M Ronne, 43Chad L Ronnebaum, 49

Magnus Ronn Phones & Addresses

  • 3 Irving St, Melrose, MA 02176 (781) 620-1181
  • Brownsville, VT
  • 1266 Davenport Ct, Erie, CO 80516 (303) 828-2935 (303) 998-0763
  • Cambridge, MA
  • 2234 Spruce St, Boulder, CO 80302

Work

Company: Tetraphase pharmaceuticals Jan 1, 2014 to Apr 2015 Position: Senior vice president, cmc

Education

School / High School: University of Colorado Boulder 1997 to 1999 Specialities: Organic Chemistry

Industries

Biotechnology

Resumes

Resumes

Magnus Ronn Photo 1

Independent Cmc Consultant

View page
Location:
3 Irving St, Melrose, MA 02176
Industry:
Biotechnology
Work:
Tetraphase Pharmaceuticals Jan 1, 2014 - Apr 2015
Senior Vice President, Cmc
Sorbus Consulting Jan 1, 2014 - Apr 2015
Independent Cmc Consultant
Tetraphase Pharmaceuticals Oct 2009 - Dec 2013
Vice President, Cmc
Tetraphase Pharmaceuticals Nov 2006 - Sep 2009
Senior Director, Pharmaceutical Sciences
Takeda Oncology 2001 - 2006
Scientist
Education:
University of Colorado Boulder 1997 - 1999
Uppsala University 1992 - 1997
Doctorates, Doctor of Philosophy Uppsala University 1989 - 1992
Bachelors, Bachelor of Science, Chemistry Emory University

Business Records

Name / Title
Company / Classification
Phones & Addresses
Magnus Ronn
Manager
SORBUS CONSULTING LLC
3 Irving St, Melrose, MA 02176

Publications

Us Patents

8-Aza Tetracycline Compounds

View page
US Patent:
20130345178, Dec 26, 2013
Filed:
Dec 31, 2012
Appl. No.:
13/731753
Inventors:
Roger B. Clark - Lexington MA, US
Minsheng He - Watertown MA, US
Louis Plamondon - Montreal, CA
Xiao-Yi Xiao - Lexington MA, US
Magnus P. Ronn - Melrose MA, US
Assignee:
Tetraphase Pharmaceuticals, Inc. - Watertown MA
International Classification:
C07D 221/18
US Classification:
514152
Abstract:
The present invention is directed to a compound represented by Structural Formula (I):

Tetracycline Compounds

View page
US Patent:
20120208788, Aug 16, 2012
Filed:
Aug 27, 2010
Appl. No.:
13/391407
Inventors:
Yonghong Deng - Watertown MA, US
Louis Plamondon - Belmont MA, US
Cuixiang Sun - Watertown MA, US
Xiao-Yi Xiao - San Diego CA, US
Jingye Zhou - Belmont MA, US
Joyce A. Sutcliffe - Newton MA, US
Magnus P. Ronn - Melrose MA, US
International Classification:
A61K 31/65
A61P 31/04
C07C 237/26
US Classification:
514152, 552205, 552202
Abstract:
The present invention is directed to a compound represented by Structural Formula (1): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.

Salts And Crystal Forms Of Gaba-A Positive Allosteric Modulator

View page
US Patent:
20200255471, Aug 13, 2020
Filed:
Nov 27, 2019
Appl. No.:
16/698057
Inventors:
- Cambridge MA, US
Kiran REDDY - Charlestown MA, US
Gabriel Martinez BOTELLA - Wayland MA, US
Magnus RONN - Melrose MA, US
Paul A. LASKAR - Napa CA, US
International Classification:
C07J 43/00
A61K 9/20
Abstract:
The invention relates to salts of Compound 1, crystalline forms thereof, methods of their preparation, pharmaceutical compositions thereof and methods of their use

Salts And Crystal Forms Of Gaba-A Positive Allosteric Modulator

View page
US Patent:
20200071350, Mar 5, 2020
Filed:
Jul 19, 2019
Appl. No.:
16/517369
Inventors:
- Cambridge MA, US
Kiran REDDY - Charlestown MA, US
Gabriel Martinez BOTELLA - Wayland MA, US
Magnus RONN - Melrose MA, US
Paul A. LASKAR - Napa CA, US
International Classification:
C07J 43/00
A61K 9/20
Abstract:
The invention relates to salts of Compound 1, crystalline forms thereof, methods of their preparation, pharmaceutical compositions thereof and methods of their use

Tetracycline Compounds

View page
US Patent:
20200048193, Feb 13, 2020
Filed:
Apr 24, 2019
Appl. No.:
16/393725
Inventors:
- Watertown MA, US
Roger B. Clark - Lexington MA, US
Diana Hunt - Cambridge MA, US
Cuixiang Sun - Arlington MA, US
Magnus P. Ronn - Melrose MA, US
Minsheng He - Andover MA, US
International Classification:
C07D 207/09
C07D 295/155
C07C 237/26
C07D 207/08
C07D 471/04
C07D 221/18
Abstract:
The present invention is directed to a compound represented by Structural Formula (I):or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I), or a pharmaceutically acceptable salt thereof, and its therapeutic use.

Semi-Synthesis Procedures

View page
US Patent:
20190210988, Jul 11, 2019
Filed:
Aug 9, 2018
Appl. No.:
16/059857
Inventors:
- Watertown MA, US
Danny LaFrance - Natick MA, US
Magnus P. Ronn - Melrose MA, US
International Classification:
C07D 295/15
C07C 237/26
C07C 245/20
C07C 231/12
C07D 207/06
Abstract:
Provided herein are improved processes for converting C7-amino-substituted tetracyclines to C7-fluoro-substituted tetracyclines, as well as intermediates produced by or used in these processes. In one embodiment, a thermal fluorination method is provided in which a suspension comprising a non-polar organic solvent and a C7-diazo-substituted tetracycline hexafluorophosphate, hexafluoroarsenate or hexafluorosilicate salt, or a salt, solvate or combination thereof, is heated to provide a C7-fluoro-substituted tetracycline, or salt, solvate or combination thereof. In another embodiment, a photolytic fluorination is provided in which a solution comprising an ionic liquid and a C7-diazo-substituted tetracycline tetrafluoroborate, hexafluorophosphate, hexafluoroarsenate or hexafluorosilicate salt, or a salt, solvate or combination thereof, is irradiated to provide a C7-fluoro-substituted tetracycline, or salt, solvate or combination thereof.

Tetracycline Compounds

View page
US Patent:
20190077803, Mar 14, 2019
Filed:
May 2, 2018
Appl. No.:
15/969537
Inventors:
- Watertown MA, US
Roger B. Clark - Lexington MA, US
Yonghong Deng - Watertown MA, US
Minsheng He - Andover MA, US
Louis Plamondon - Montreal, CA
Cuixiang Sun - Arlington MA, US
Xiao-Yi Xiao - Lexington MA, US
Magnus P. Ronn - Melrose MA, US
International Classification:
C07D 471/10
C07C 237/26
C07D 207/14
C07D 207/16
C07D 209/14
C07D 209/52
C07D 223/14
C07D 261/20
C07D 295/135
C07D 295/185
C07D 295/26
C07D 307/22
C07D 401/04
C07D 413/06
C07D 207/09
C07D 295/155
C07D 295/15
C07D 295/13
C07D 223/32
C07D 223/04
C07D 221/20
C07D 213/74
C07D 211/34
C07D 211/14
C07D 209/44
C07D 209/04
C07D 207/10
C07D 207/08
C07D 207/06
C07D 205/04
C07C 311/19
C07C 311/06
C07C 275/24
Abstract:
The present invention is directed to a compound represented by Structural Formula (I):or a pharmaceutically acceptable salt thereof. The variables for Structural Formula I are defined herein.Also described is a pharmaceutical composition comprising the compound of Structural Formula I and its therapeutic use.

Tetracycline Compounds

View page
US Patent:
20170334841, Nov 23, 2017
Filed:
Mar 1, 2017
Appl. No.:
15/446831
Inventors:
- Watertown MA, US
Louis Plamondon - Quebec, CA
Cuixiang Sun - Arlington MA, US
Xiao-Yi Xiao - Lexington MA, US
Jingye Zhou - Shanghai, CN
Joyce A. Sutcliffe - Newton MA, US
Magnus P. Ronn - Melrose MA, US
International Classification:
C07C 311/08
C07D 295/15
C07C 237/26
C07C 307/10
C07C 311/09
C07C 311/13
C07C 311/21
C07C 311/29
C07C 311/44
C07D 233/84
C07D 233/60
C07D 231/18
C07D 223/06
C07D 213/82
C07D 213/74
C07D 213/70
C07D 211/60
C07D 211/54
C07D 209/52
C07D 209/44
C07D 207/16
C07D 207/12
C07D 205/04
C07D 307/64
C07C 2603/46
C07C 2601/02
C07C 2603/40
C07C 2603/44
C07C 2601/16
C07C 2601/04
C07C 2601/14
C07C 2601/08
Abstract:
The present invention is directed to a compound represented by Structural Formula (I):or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.

Isbn (Books And Publications)

Industriarkitektur: Om Prisbelonade Industrihusprojekt

View page
Author

Magnus Ronn

ISBN #

9170070059

Tillstand Soks: Om Foretag Som overklagar Bygglov

View page
Author

Magnus Ronn

ISBN #

9170070067

Ralph Erskine: Som Industriarkitet

View page
Author

Magnus Ronn

ISBN #

9173329088

Control profile
Magnus P Ronn from Melrose, MA, age ~58 Get Report